Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.

Robinson K, Chamberlain LM, Lopez MC, Rush CM, Marcotte H, Le Page RW, Wells JM.

Infect Immun. 2004 May;72(5):2753-61.

2.

Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis.

Gilbert C, Robinson K, Le Page RW, Wells JM.

Infect Immun. 2000 Jun;68(6):3251-60.

3.

6-Phosphogluconate dehydrogenase from Lactococcus lactis: a role for arginine residues in binding substrate and coenzyme.

Tetaud E, Hanau S, Wells JM, Le Page RW, Adams MJ, Arkison S, Barrett MP.

Biochem J. 1999 Feb 15;338 ( Pt 1):55-60.

4.

Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine.

Steidler L, Robinson K, Chamberlain L, Schofield KM, Remaut E, Le Page RW, Wells JM.

Infect Immun. 1998 Jul;66(7):3183-9.

5.

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.

Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW.

Nat Biotechnol. 1997 Jul;15(7):653-7.

PMID:
9219268
6.

A single locus minisatellite sequence which distinguishes between Trypanosoma brucei isolates.

Barrett MP, MacLeod A, Tovar J, Sweetman JP, Tait A, Le Page RW, Melville SE.

Mol Biochem Parasitol. 1997 May;86(1):95-9. No abstract available.

PMID:
9178271
7.

Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C.

Norton PM, Wells JM, Brown HW, Macpherson AM, Le Page RW.

Vaccine. 1997 Apr-May;15(6-7):616-9.

PMID:
9178460
8.

Lactic acid bacteria as vaccine delivery vehicles.

Wells JM, Robinson K, Chamberlain LM, Schofield KM, Le Page RW.

Antonie Van Leeuwenhoek. 1996 Oct;70(2-4):317-30. Review. No abstract available.

PMID:
8879413
9.

Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis.

Norton PM, Brown HW, Wells JM, Macpherson AM, Wilson PW, Le Page RW.

FEMS Immunol Med Microbiol. 1996 Jun;14(2-3):167-77.

PMID:
8809553
10.

An origin of DNA replication from Lactococcus lactis bacteriophage c2.

Waterfield NR, Lubbers MW, Polzin KM, Le Page RW, Jarvis AW.

Appl Environ Microbiol. 1996 Apr;62(4):1452-3.

11.

Sequencing and analysis of the prolate-headed lactococcal bacteriophage c2 genome and identification of the structural genes.

Lubbers MW, Waterfield NR, Beresford TP, Le Page RW, Jarvis AW.

Appl Environ Microbiol. 1995 Dec;61(12):4348-56.

12.
13.

Progress in the development of Lactococcus lactis as a recombinant mucosal vaccine delivery system.

Norton PM, Le Page RW, Wells JM.

Folia Microbiol (Praha). 1995;40(3):225-30. Review.

PMID:
8919927
14.

Lon and Clp-like ATP-dependent proteases of Lactococcus lactis.

Coward C, Le Page RW, Wells JM.

Dev Biol Stand. 1995;85:481-6. No abstract available.

PMID:
8586220
15.

Mucosal and systemic responses following enteric exposure to lactic acid bacteria.

Norton PM, Brown HW, Le Page RW.

Adv Exp Med Biol. 1995;371B:1559-62. No abstract available.

PMID:
7502856
16.

The immune response to Lactococcus lactis: implications for its use as a vaccine delivery vehicle.

Norton PM, Brown HW, Le Page RW.

FEMS Microbiol Lett. 1994 Jul 15;120(3):249-56.

PMID:
8076800
17.

Overexpression in Escherichia coli and purification of the 6-phosphogluconate dehydrogenase of Trypanosoma brucei.

Barrett MP, Phillips C, Adams MJ, Le Page RW.

Protein Expr Purif. 1994 Feb;5(1):44-9.

PMID:
8167473
18.

A model system for the investigation of heterologous protein secretion pathways in Lactococcus lactis.

Wells JM, Wilson PW, Norton PM, Le Page RW.

Appl Environ Microbiol. 1993 Nov;59(11):3954-9.

19.

Preliminary crystallographic study of 6-phosphogluconate dehydrogenase from Trypanosoma brucei.

Phillips C, Barrett MP, Gover S, Le Page RW, Adams MJ.

J Mol Biol. 1993 Sep 20;233(2):317-21.

PMID:
8377207
20.

Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge.

Wells JM, Wilson PW, Norton PM, Gasson MJ, Le Page RW.

Mol Microbiol. 1993 Jun;8(6):1155-62.

PMID:
8361360
21.

Improved cloning vectors and transformation procedure for Lactococcus lactis.

Wells JM, Wilson PW, Le Page RW.

J Appl Bacteriol. 1993 Jun;74(6):629-36.

PMID:
8349525
22.

A 6-phosphogluconate dehydrogenase gene from Trypanosoma brucei.

Barrett MP, Le Page RW.

Mol Biochem Parasitol. 1993 Jan;57(1):89-99.

PMID:
8426618
23.

Genetic evidence that metacyclic forms of Trypanosoma brucei are diploid.

Tait A, Turner CM, Le Page RW, Wells JM.

Mol Biochem Parasitol. 1989 Dec;37(2):247-55.

PMID:
2575222
24.

Gene exchange in African trypanosomes: frequency and allelic segregation.

Sternberg J, Turner CM, Wells JM, Ranford-Cartwright LC, Le Page RW, Tait A.

Mol Biochem Parasitol. 1989 May 15;34(3):269-79.

PMID:
2567494
25.

Nuclear factors binding to the mini-exon repeat of Trypanosoma brucei.

Koronakis VE, Ross AM, Le Page RW, Hughes C.

Mol Biochem Parasitol. 1988 Jul;30(1):89-96.

PMID:
3398890
26.

Gene exchange in African trypanosomes: characterisation of a new hybrid genotype.

Sternberg J, Tait A, Haley S, Wells JM, Le Page RW, Schweizer J, Jenni L.

Mol Biochem Parasitol. 1988 Jan 15;27(2-3):191-200.

PMID:
2893975
27.

DNA contents and molecular karyotypes of hybrid Trypanosoma brucei.

Wells JM, Prospero TD, Jenni L, Le Page RW.

Mol Biochem Parasitol. 1987 May;24(1):103-16.

PMID:
2886912
28.

Hybrid formation between African trypanosomes during cyclical transmission.

Jenni L, Marti S, Schweizer J, Betschart B, Le Page RW, Wells JM, Tait A, Paindavoine P, Pays E, Steinert M.

Nature. 1986 Jul 10-16;322(6075):173-5.

PMID:
3724860
29.

Short term cultivation of Trypanosoma brucei in vitro at 37 degrees C.

Le Page RW.

Nature. 1967 Dec 16;216(5120):1141-2. No abstract available.

PMID:
6075268

Supplemental Content

Loading ...
Support Center